Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2021-03-16 5:04 pm Purchase |
2021-03-11 | 13D | Lineage Cell Therapeutics, Inc. LCTX |
BROADWOOD PARTNERS LP | 34,247,167 21.200% |
34,247,167 (New Position) |
Filing History |
| 2021-02-09 5:10 pm Purchase |
2021-02-05 | 13D | OncoCyte Corporation OCX |
BROADWOOD PARTNERS LP | 891,780 20.100% |
30,000 (+3.48%) |
Filing History |
| 2021-01-28 5:25 pm Sale |
2021-01-26 | 13D | STAAR Surgical Company STAA |
BROADWOOD PARTNERS LP | 9,925,922 21.500% |
-895,326 (-8.27%) |
Filing History |
| 2021-01-22 4:18 pm Purchase |
2021-01-20 | 13D | OncoCyte Corporation OCX |
BROADWOOD PARTNERS LP | 861,780 21.600% |
253,911 (+41.77%) |
Filing History |
| 2020-08-12 5:05 pm Sale |
2020-08-05 | 13D | STAAR Surgical Company STAA |
BROADWOOD PARTNERS LP | 10,821,248 23.600% |
-59,831 (-0.55%) |
Filing History |